ATT contraindicated in pregnant women
**Core Concept**
The administration of aminoglycoside antibiotics, such as gentamicin, through atrial or ventricular assist devices (ATT) can lead to ototoxicity and nephrotoxicity. This is particularly concerning during pregnancy due to the potential effects on the fetus.
**Why the Correct Answer is Right**
The primary concern with ATT in pregnant women is the risk of ototoxicity. Aminoglycosides can cause damage to the inner ear structures, leading to hearing loss or tinnitus. Additionally, the kidneys of a pregnant woman are already under increased stress, and the nephrotoxic effects of aminoglycosides can exacerbate this issue. The developing fetus is also susceptible to the effects of these antibiotics, which can lead to congenital abnormalities or other complications.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is not provided.
* **Option B:** There is no clear evidence that ATT is contraindicated in pregnant women due to the risk of maternal or fetal hypokalemia.
* **Option C:** While aminoglycosides can cause maternal and fetal hypokalemia, this is not the primary reason for their contraindication in pregnancy.
* **Option D:** There is no direct evidence that ATT is contraindicated in pregnant women due to the risk of maternal or fetal hypocalcemia.
**Clinical Pearl / High-Yield Fact**
Aminoglycosides can cause ototoxicity, and the risk is increased in pregnant women. It is essential to use these antibiotics judiciously and consider alternative options when possible.
**Correct Answer:** None provided